---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-028854"
form_type: "8-K"
ticker: "LUCD"
cik: "0001799011"
company_name: "Lucid Diagnostics Inc."
filed_at: "2024-07-24T23:59:59+00:00"
generated_at: "2026-05-31T17:04:07.890672+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Lucid Diagnostics shareholders approve increase in authorized shares, re-elect directors

## Summary
- Stockholders re-elected Dr. Lishan Aklog, Debra White, and Dennis Matheis as Class C directors.
- Approved amendment to increase authorized common stock from 200M to 300M shares.
- Approved issuance of shares under Series B and B-1 Convertible Preferred Stock for Nasdaq Listing Rule 5635.
- Ratified appointment of Marcum LLP as independent auditor for FY 2024.

## SEC filing metadata
- accession: 0001493152-24-028854
- form_type: 8-K
- ticker: LUCD
- cik: 0001799011
- company_name: Lucid Diagnostics Inc.
- filed_at: 2024-07-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799011/000149315224028854/0001493152-24-028854-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799011/000149315224028854/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-028854
- JSON: https://secwatch.observer/filing/0001493152-24-028854.json
- Plain text: https://secwatch.observer/filing/0001493152-24-028854.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.